Tango Therapeutics TNGX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's EPS (basic)?
- Tango Therapeutics (TNGX) reported EPS (basic) of -$0.32 in Q1 2026.
- How has Tango Therapeutics's EPS (basic) changed year-over-year?
- Tango Therapeutics's EPS (basic) increased by 11.1% year-over-year, from -$0.36 to -$0.32.
- What is the long-term trend for Tango Therapeutics's EPS (basic)?
- Over 4 years (2021 to 2025), Tango Therapeutics's EPS (basic) has grown at a -1.9% compound annual growth rate (CAGR), from -$0.94 to -$0.87.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.